HarvestR

Innovative dsrna-based biopesticides for sustainable crop protection

Technology
In development
Company

HarvestR presents dsRNA-based biopesticides targeting pathogenic fungi, enhancing crop protection with minimal environmental impact. Validated against Botrytis cinerea, this technology offers a non-toxic, GMO-free alternative to chemical fungicides, with plans for broader pathogen application.

Overview

HarvestR introduces a pioneering dsRNA-based biopesticide technology designed to enhance crop protection and sustainability. Focusing on fungal-specific solutions, this innovation targets pathogenic fungi with precision, aiming to reduce global crop losses attributed to fungal diseases. Unlike traditional chemical fungicides, this approach is non-toxic, environmentally friendly, and GMO-free, making it an ideal addition to sustainable agricultural practices. Early validation has demonstrated its efficacy against Botrytis cinerea, promising broader applications across diverse crops and multiple fungal pathogens.

Technical specifications

Key features:

  • Specific targeting of pathogenic fungi using dsRNA technology, minimizing collateral environmental impact.
  • Proven effectiveness in commercial settings against Botrytis cinerea, with potential expansion to other pathogens like Colletotrichum.
  • Non-toxic and GMO-free formulation, enhancing safety and environmental compatibility.
  • Integration potential into existing agricultural portfolios, providing a seamless transition for users.

Planned advancements:

  • Scaling studies to validate efficacy against a wider range of fungal pathogens.
  • Development of multi-target dsRNA constructs for simultaneous inhibition of several fungal species.
  • Exploration of delivery systems such as LDH to optimize effectiveness and crop protection.
Technology readiness level

The current technology readiness level is 5, indicating that the technology has been validated in relevant environments and is advancing towards broader commercial applications. Future validation efforts will focus on scaling, multi-pathogen targeting, and regulatory compliance to ensure market readiness.

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.